CNTRL and in situ carcinoma: Treatment with CIS, GLSi and xCTi alone, respectively as well as their dual and triple combinations reduced cellular GSH significantly compared to CNTRL in resistant cells (P < 0.001, Fig. 6D and Fig. 4B).